Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm

Grünenthal Group Germany South Korea

| Instagram: grunenthal

About BCWorldPharm
BCWorld Pharm Co., Ltd. is a KOSDAQ-listed South Korean specialty pharmaceutical company with a strong presence in the domestic pain market. The company is expanding its portfolio through global partnerships, including its recently expanded collaboration on Nucynta®. Under its Vision 2030 strategy, BCWorld Pharm aims to strengthen its leadership in specialty pain care in Korea and beyond."

More information: www.bcwp.co.kr/eng/

Media Contacts

 

Grünenthal

Maren Thurow

Head Global Communication

Phone: [phone] 

[e-mail] 

BCWorld Pharm

Jin Ho Lee

Manager, Strategic Planning

Phone: [phone]

[e-mail] 

 

View original content:https://www.prnewswire.co.uk/news-releases/grunenthal-licenses-exclusive-south-korean-rights-to-qutenza-to-bcworld-pharm-302705159.html